Reflections on Medicine and Life by Dr. S.P. Kalantri
Clinical stories and reflections on evidence-based medicine, research, and patient care.
Dolo 650. Almost unheard of before Covid hit us, the brand became a name, the country began to associate paracetamol with. Data suggest that the consumption of painkillers shot up by 23% in India last year. Has the pandemic turned us into excessive pill-poppers? Devina Sengupta spoke to me, ET Prime’s Vikas Dandekar and ET’s … Read more
Molnupiravir. Another drug that has created a lot of hype or hope among public. But does it really deliver what it promises?
The ICMR has increasingly drawn criticism from India’s doctors and scientists, who have questioned its drug recommendations & lack of transparency on data related to variants. Countrywide, doctors started writing these prescriptions, which artificially inflated the cost for Covid management,” I said. “Big Pharma was laughing all the way to the bank and ultimately the … Read more
Covid 19 and children. There is just a one in hundred chance that a child would test positive for Covid and would require a hospital admission.
High hospital bills and black marketing of drugs and oxygen make the treatment of Covid-19 prohibitively expensive. Malini Aisola, co-convenor of the All India Drug Action Network, ET’s Kiran Somvanshi and I discuss the flaws in the existing setup and the steps to fix the financial burden of Covid-19.